142 related articles for article (PubMed ID: 34840085)
21. Predictors of Drug-Resistant Epilepsy in Tuberous Sclerosis Complex.
Jeong A; Nakagawa JA; Wong M
J Child Neurol; 2017 Dec; 32(14):1092-1098. PubMed ID: 29129154
[TBL] [Abstract][Full Text] [Related]
22. Long-term cognitive outcomes in tuberous sclerosis complex.
Tye C; Mcewen FS; Liang H; Underwood L; Woodhouse E; Barker ED; Sheerin F; Yates JRW; Bolton PF;
Dev Med Child Neurol; 2020 Mar; 62(3):322-329. PubMed ID: 31538337
[TBL] [Abstract][Full Text] [Related]
23. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review.
Hancock E; Osborne JP
J Child Neurol; 1999 Feb; 14(2):71-4. PubMed ID: 10073425
[TBL] [Abstract][Full Text] [Related]
24. Sirolimus treatment for tuberous sclerosis complex prior to epilepsy: Evidence from a registry-based real-world study.
Shen YW; Wang YY; Zhang MN; Xu Y; Lu Q; He W; Chen HM; Liu LY; Pang LY; Wang QH; Dun S; Li YF; Gao J; Han F; Zou LP
Seizure; 2022 Apr; 97():23-31. PubMed ID: 35286974
[TBL] [Abstract][Full Text] [Related]
25. Predicting Antiseizure Medication Treatment in Children with Rare Tuberous Sclerosis Complex-Related Epilepsy Using Deep Learning.
Wang H; Hu Z; Jiang D; Lin R; Zhao C; Zhao X; Zhou Y; Zhu Y; Zeng H; Liang D; Liao J; Li Z
AJNR Am J Neuroradiol; 2023 Dec; 44(12):1373-1383. PubMed ID: 38081677
[TBL] [Abstract][Full Text] [Related]
26. CSF nerve growth factor (β-NGF) is increased but CSF insulin-like growth factor-(IGF-1) is normal in children with tuberous sclerosis and infantile spasms.
Riikonen R; Kokki H
Eur J Paediatr Neurol; 2019 Jan; 23(1):191-196. PubMed ID: 30503720
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review.
Prezioso G; Chiarelli F; Matricardi S
Expert Rev Neurother; 2023; 23(7):661-671. PubMed ID: 37243682
[TBL] [Abstract][Full Text] [Related]
28. Tuberous sclerosis complex: correlation of magnetic resonance imaging (MRI) findings with comorbidities.
Wong V; Khong PL
J Child Neurol; 2006 Feb; 21(2):99-105. PubMed ID: 16566871
[TBL] [Abstract][Full Text] [Related]
29. Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex.
Goh S; Kwiatkowski DJ; Dorer DJ; Thiele EA
Neurology; 2005 Jul; 65(2):235-8. PubMed ID: 16043792
[TBL] [Abstract][Full Text] [Related]
30. Neurodevelopmental Outcomes of a Cohort of Children with Tuberous Sclerosis Complex with Epileptic Spasms.
Saini L; Mukherjee S; Gunasekaran PK; Malhi P; Saini AG; Sharma R; Sharawat IK; Suthar R; Sahu JK; Sankhyan N
Neuropediatrics; 2023 Oct; 54(5):335-338. PubMed ID: 37379859
[TBL] [Abstract][Full Text] [Related]
31. Infantile spasms and early-onset progressive polycystic renal lesions associated with TSC2/PKD1 contiguous gene deletion syndrome.
Matsubara Y; Akamine S; Chong PF; Kawakami S; Maehara K; Kaku Y; Kurokawa M; Morisada N; Iijima K; Kira R
Seizure; 2021 Mar; 86():82-84. PubMed ID: 33581549
[No Abstract] [Full Text] [Related]
32. Epilepsy Is Heterogeneous in Early-Life Tuberous Sclerosis Complex.
Ihnen SKZ; Capal JK; Horn PS; Griffith M; Sahin M; Bebin EM; Wu JY; Northrup H; Krueger DA;
Pediatr Neurol; 2021 Oct; 123():1-9. PubMed ID: 34343869
[TBL] [Abstract][Full Text] [Related]
33. Tuberous sclerosis and infantile spasms.
Riikonen R; Simell O
Dev Med Child Neurol; 1990 Mar; 32(3):203-9. PubMed ID: 2155840
[TBL] [Abstract][Full Text] [Related]
34. Tuberous sclerosis as an underlying basis for infantile spasm.
Yeung RS
Int Rev Neurobiol; 2002; 49():315-32. PubMed ID: 12040899
[TBL] [Abstract][Full Text] [Related]
35. Isolated cortical tuber in an infant with genetically confirmed tuberous sclerosis complex 1 presenting with symptomatic West syndrome.
Miyata H; Fushimi S; Ota Y; Vinters HV; Adachi K; Nanba E; Akiyama T
Neuropathology; 2021 Feb; 41(1):58-64. PubMed ID: 33181865
[TBL] [Abstract][Full Text] [Related]
36. Increased electroencephalography connectivity precedes epileptic spasm onset in infants with tuberous sclerosis complex.
Davis PE; Kapur K; Filip-Dhima R; Trowbridge SK; Little E; Wilson A; Leuchter A; Bebin EM; Krueger D; Northrup H; Wu JY; Sahin M; Peters JM;
Epilepsia; 2019 Aug; 60(8):1721-1732. PubMed ID: 31297797
[TBL] [Abstract][Full Text] [Related]
37. Tuberous sclerosis: a survey of 97 cases. I: Seizures, pertussis immunisation and handicap.
Hunt A
Dev Med Child Neurol; 1983 Jun; 25(3):346-9. PubMed ID: 6873497
[TBL] [Abstract][Full Text] [Related]
38. Manifestations of Tuberous Sclerosis Complex: The Experience of a Provincial Clinic.
Wilbur C; Sanguansermsri C; Chable H; Anghelina M; Peinhof S; Anderson K; Steinbok P; Singhal A; Datta A; Connolly MB
Can J Neurol Sci; 2017 Jan; 44(1):35-43. PubMed ID: 28004629
[TBL] [Abstract][Full Text] [Related]
39. Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study.
Nabbout R; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D Amato L; d'Augères GB; de Vries PJ; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen A; Kingswood JC;
Epilepsia Open; 2019 Mar; 4(1):73-84. PubMed ID: 30868117
[TBL] [Abstract][Full Text] [Related]
40. Management of epilepsy in tuberous sclerosis complex.
Curatolo P; D'Argenzio L; Cerminara C; Bombardieri R
Expert Rev Neurother; 2008 Mar; 8(3):457-67. PubMed ID: 18345974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
